Stories by: Tanya Hollis

Medical device company Polartechnics (ASX:PLT) today announced it had secured commitments to raise $5 million to assist in international marketing of its three core products.

Brisbane's Progen Industries (ASX:PGL) will take on production of an anti-cancer therapeutic vaccine for Prima Biomed's (ASX:PRR) Cancer Vac subsidiary.

Australian researchers have discovered two genes that are critical to understanding elite athletic performance, an Athens conference has heard.

Sydney-based Brain Resource Company (ASX:BRC) has cracked into the biotechnology sector with a deal to provide its profiles of brain function and cognition to Biogen in the United States.

Diagnostics group Visiomed (ASX:VSG) has entered a German research collaboration to develop surgical navigation systems for spinal procedures.

Circadian Technologies (ASX:CIR) has added another string to its neuroscience bow with an investment in new Melbourne research.

Norwood Abbey (ASX:NAL) is on track to list its immunology spin-off in the United Kingdom within six months.

A United States decision to approve reimbursement of Ventricular Assist Devices has come as good news to Australian artificial heart developer Ventracor (ASX:VCR).

Biomedical nanotechnology company pSivida (ASX:PSD) will strengthen its stake in its United Kingdom operating subsidiary following a AUD$6.5 million capital raising, the biotech announced today.

Optiscan Imaging's (ASX: OIL) partnership with Japan's Pentax Corporation to develop a flexible endomicroscope has taken another step forward with the Melbourne biotech receiving its first major order for the supply of components.